QUIDELORTHO CORP (QDEL) Stock Fundamental Analysis
NASDAQ:QDEL - Nasdaq - US2197981051 - Common Stock - Currency: USD
Overall QDEL gets a fundamental rating of 3 out of 10. We evaluated QDEL against 187 industry peers in the Health Care Equipment & Supplies industry. While QDEL is still in line with the averages on profitability rating, there are concerns on its financial health. QDEL is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
QDEL had positive earnings in the past year.
In the past year QDEL had a positive cash flow from operations.
In multiple years QDEL reported negative net income over the last 5 years.
Each year in the past 5 years QDEL had a positive operating cash flow.
1.2 Ratios
The Return On Assets of QDEL (-5.55%) is better than 66.31% of its industry peers.
QDEL has a better Return On Equity (-11.97%) than 65.78% of its industry peers.
The Return On Invested Capital of QDEL (1.25%) is better than 68.45% of its industry peers.
The Average Return On Invested Capital over the past 3 years for QDEL is below the industry average of 7.89%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.55% | ||
| ROE | -11.97% | ||
| ROIC | 1.25% |
ROA(3y)-8.62%
ROA(5y)9.28%
ROE(3y)-19.28%
ROE(5y)7.89%
ROIC(3y)4.37%
ROIC(5y)20.45%
1.3 Margins
QDEL has a Operating Margin of 3.11%. This is in the better half of the industry: QDEL outperforms 68.45% of its industry peers.
QDEL's Operating Margin has declined in the last couple of years.
The Gross Margin of QDEL (46.94%) is comparable to the rest of the industry.
QDEL's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.11% | ||
| PM (TTM) | N/A | ||
| GM | 46.94% |
OM growth 3Y-68.75%
OM growth 5Y-39.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.83%
GM growth 5Y-5.07%
2. Health
2.1 Basic Checks
QDEL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
QDEL has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, QDEL has more shares outstanding
The debt/assets ratio for QDEL is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.89, we must say that QDEL is in the distress zone and has some risk of bankruptcy.
QDEL has a Altman-Z score (0.89) which is in line with its industry peers.
A Debt/Equity ratio of 0.70 indicates that QDEL is somewhat dependend on debt financing.
QDEL has a Debt to Equity ratio of 0.70. This is in the lower half of the industry: QDEL underperforms 70.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.7 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.89 |
ROIC/WACC0.17
WACC7.25%
2.3 Liquidity
A Current Ratio of 1.20 indicates that QDEL should not have too much problems paying its short term obligations.
QDEL has a worse Current ratio (1.20) than 83.42% of its industry peers.
A Quick Ratio of 0.66 indicates that QDEL may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.66, QDEL is doing worse than 91.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.2 | ||
| Quick Ratio | 0.66 |
3. Growth
3.1 Past
The earnings per share for QDEL have decreased strongly by -22.38% in the last year.
Measured over the past years, QDEL shows a decrease in Earnings Per Share. The EPS has been decreasing by -9.03% on average per year.
Looking at the last year, QDEL shows a decrease in Revenue. The Revenue has decreased by -3.42% in the last year.
Measured over the past years, QDEL shows a very strong growth in Revenue. The Revenue has been growing by 39.07% on average per year.
EPS 1Y (TTM)-22.38%
EPS 3Y-52.97%
EPS 5Y-9.03%
EPS Q2Q%68.18%
Revenue 1Y (TTM)-3.42%
Revenue growth 3Y17.89%
Revenue growth 5Y39.07%
Sales Q2Q%-2.56%
3.2 Future
Based on estimates for the next years, QDEL will show a very strong growth in Earnings Per Share. The EPS will grow by 25.08% on average per year.
Based on estimates for the next years, QDEL will show a small growth in Revenue. The Revenue will grow by 2.31% on average per year.
EPS Next Y32.61%
EPS Next 2Y33.45%
EPS Next 3Y32.58%
EPS Next 5Y25.08%
Revenue Next Year-2.19%
Revenue Next 2Y0.97%
Revenue Next 3Y2.23%
Revenue Next 5Y2.31%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 14.11 indicates a correct valuation of QDEL.
Based on the Price/Earnings ratio, QDEL is valued cheaper than 88.24% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.30, QDEL is valued a bit cheaper.
The Price/Forward Earnings ratio is 9.21, which indicates a very decent valuation of QDEL.
Based on the Price/Forward Earnings ratio, QDEL is valued cheaper than 94.65% of the companies in the same industry.
QDEL is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.11 | ||
| Fwd PE | 9.21 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, QDEL is valued cheaper than 94.12% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 8.32 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as QDEL's earnings are expected to grow with 32.58% in the coming years.
PEG (NY)0.43
PEG (5Y)N/A
EPS Next 2Y33.45%
EPS Next 3Y32.58%
5. Dividend
5.1 Amount
No dividends for QDEL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
30.34
-1.21 (-3.84%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners112.09%
Inst Owner Change0%
Ins Owners0.54%
Ins Owner Change2.37%
Market Cap2.05B
Analysts78.67
Price Target51.29 (69.05%)
Short Float %6.06%
Short Ratio2.41
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.18%
Min EPS beat(2)4.59%
Max EPS beat(2)23.78%
EPS beat(4)4
Avg EPS beat(4)65.27%
Min EPS beat(4)4.59%
Max EPS beat(4)162.15%
EPS beat(8)6
Avg EPS beat(8)33.31%
EPS beat(12)9
Avg EPS beat(12)36.06%
EPS beat(16)12
Avg EPS beat(16)30.37%
Revenue beat(2)0
Avg Revenue beat(2)-1.13%
Min Revenue beat(2)-1.51%
Max Revenue beat(2)-0.75%
Revenue beat(4)2
Avg Revenue beat(4)2.64%
Min Revenue beat(4)-1.51%
Max Revenue beat(4)11.02%
Revenue beat(8)5
Avg Revenue beat(8)1.16%
Revenue beat(12)8
Avg Revenue beat(12)1.78%
Revenue beat(16)11
Avg Revenue beat(16)4.61%
PT rev (1m)0%
PT rev (3m)-5.88%
EPS NQ rev (1m)22.58%
EPS NQ rev (3m)-92.86%
EPS NY rev (1m)1.18%
EPS NY rev (3m)0.98%
Revenue NQ rev (1m)-0.14%
Revenue NQ rev (3m)-2.06%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)0.18%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.11 | ||
| Fwd PE | 9.21 | ||
| P/S | 0.74 | ||
| P/FCF | N/A | ||
| P/OCF | 13.74 | ||
| P/B | 0.68 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.32 |
EPS(TTM)2.15
EY7.09%
EPS(NY)3.29
Fwd EY10.86%
FCF(TTM)-0.53
FCFYN/A
OCF(TTM)2.21
OCFY7.28%
SpS40.88
BVpS44.32
TBVpS-5.49
PEG (NY)0.43
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.55% | ||
| ROE | -11.97% | ||
| ROCE | 1.59% | ||
| ROIC | 1.25% | ||
| ROICexc | 1.28% | ||
| ROICexgc | 3.54% | ||
| OM | 3.11% | ||
| PM (TTM) | N/A | ||
| GM | 46.94% | ||
| FCFM | N/A |
ROA(3y)-8.62%
ROA(5y)9.28%
ROE(3y)-19.28%
ROE(5y)7.89%
ROIC(3y)4.37%
ROIC(5y)20.45%
ROICexc(3y)4.54%
ROICexc(5y)30.14%
ROICexgc(3y)17.29%
ROICexgc(5y)56.29%
ROCE(3y)5.53%
ROCE(5y)25.88%
ROICexcg growth 3Y-72.1%
ROICexcg growth 5Y-43.85%
ROICexc growth 3Y-77.1%
ROICexc growth 5Y-42.97%
OM growth 3Y-68.75%
OM growth 5Y-39.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.83%
GM growth 5Y-5.07%
F-Score5
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.7 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.96 | ||
| Cap/Depr | 41.56% | ||
| Cap/Sales | 6.7% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 28.09% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.2 | ||
| Quick Ratio | 0.66 | ||
| Altman-Z | 0.89 |
F-Score5
WACC7.25%
ROIC/WACC0.17
Cap/Depr(3y)46.16%
Cap/Depr(5y)161.74%
Cap/Sales(3y)6.1%
Cap/Sales(5y)7.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.38%
EPS 3Y-52.97%
EPS 5Y-9.03%
EPS Q2Q%68.18%
EPS Next Y32.61%
EPS Next 2Y33.45%
EPS Next 3Y32.58%
EPS Next 5Y25.08%
Revenue 1Y (TTM)-3.42%
Revenue growth 3Y17.89%
Revenue growth 5Y39.07%
Sales Q2Q%-2.56%
Revenue Next Year-2.19%
Revenue Next 2Y0.97%
Revenue Next 3Y2.23%
Revenue Next 5Y2.31%
EBIT growth 1Y-34.7%
EBIT growth 3Y-63.16%
EBIT growth 5Y-15.19%
EBIT Next Year933.72%
EBIT Next 3Y133.74%
EBIT Next 5Y88.95%
FCF growth 1Y-109.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-73.95%
OCF growth 3Y-53.13%
OCF growth 5Y-9.2%